Physician profile
Jamie E Kim
NPI 1225187388
$3,204.70
in general payments reported to CMS, 2019-2025
23 companies · $523 in 2025
The $523 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $304 · 2021: $772 · 2022: $694 · 2023: $391 · 2024: $52.88 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $873 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $872.65 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,204.15 | 2019-2023 | |
| Myovant Sciences INC. | $295.17 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $261.10 | 2023-2025 | Myfembree |
| Organon LLC | $244.49 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $208.81 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $144.54 | 2019-2022 | |
| Hologic Sales and Service, LLC | $116.86 | 2019-2023 | Aptima |
| Coopersurgical, INC. | $103.52 | 2019-2025 | Paragard T 380a |
| Avion Pharmaceuticals | $88.54 | 2021-2023 | Balcoltra |
| Allergan, INC. | $87.35 | 2019-2020 | |
| Boston Scientific Corporation | $77.78 | 2025 | Farapulse |
| Merck Sharp & Dohme LLC | $65.56 | 2019-2021 | |
| Exeltis, USA INC. | $46.55 | 2022-2025 | Slynd |
| Amag Pharmaceuticals, INC. | $45.34 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.54 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $34.45 | 2022-2023 | |
| Biogen, INC. | $28.17 | 2025 | Zurzuvae |
| Integra Lifesciences Corporation | $23.63 | 2025 | Tcc-Ez |
| Acella Pharmaceuticals, LLC | $23.19 | 2025 | NP Thyroid 60 |
| Novo Nordisk INC | $21.41 | 2022 | |
| Mayne Pharma Commercial LLC | $17.19 | 2023 | |
| Medicem INC. | $16.41 | 2021 | |
| Convatec INC. | $14.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.